Rally for Medical Research planned 9/14 in Washington, DC


The Ad Hoc Group for Medical Research published an ad in the Wall Street Journal and Politico on May 23, 2017, thanking Congress for its support of medical research and recommending continued progress in FY 2018.

The Ad Hoc Group for Medical Research is a coalition of patient and voluntary health groups, medical and scientific societies, academic and research organizations, and industry that support enhancing the federal investment in the biomedical, behavioral, and population-based research conducted and supported by the NIH.

More than 300 organizations and institutions across the NIH stakeholder community recommend $36.2 billion for NIH in FY 2018, including funds provided through the 21st Century Cures Act. This $2 billion increase to the NIH base would enable real growth over biomedical inflation as an important step to stabilizing the nation’s research capacity over the long term. Read the full recommendation and list of endorsers here.

The group is planning the Rally for Medical Research. For five consecutive years, the Rally for Medical Research Hill Day has raised awareness during a critical time about the urgent need for an increased investment in the NIH to improve health, spur more progress, inspire more hope and save more lives. The Rally for Medical Research Hill Day is scheduled to take place on Thursday, Sept. 14, in Washington, DC. A reception will take place on Wednesday, Sept. 13 on Capitol Hill from 5:30 to 7:30 pm following a Hill Day training session at 3:00 pm at the Grand Hyatt. Additionally, a hotel room block has been reserved on a first come, first served basis at the Grand Hyatt, Washington DC. Specific questions may be directed to info@rallyformedicalresearch.org and for organizations interested in sponsoring the event, more information is available at: http://rallyformedicalresearch.org/Pages/Hill-DaySponsors-2017.aspx. Follow the Rally on Twitter @RallyforNIH or join the group on Facebook https://www.facebook.com/RallyMedRes/

Leave a comment

Your email address will not be published. Required fields are marked *